Balmain, Allan http://orcid.org/0000-0001-6549-7861
Funding for this research was provided by:
Cancer Research UK (C98/A24032)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA210018, UO1CA176287)
Article History
Received: 18 May 2020
Accepted: 25 September 2020
First Online: 26 October 2020
Competing interests
: A.B. is a member of the Scientific Advisory Board of Mission Bio, Inc. and has received funding support from Novartis and Bristol Myers Squibb.